Pr Stéphane Oudard
- Spécialité
- Oncologue médical, expert urologie
- Titre
- Chef de service
- Hôpital
- Hôpital Européen Georges Pompidou (Paris)
- Derniers articles
-
- Feasibility of standard versus fractionated carboplatin-paclitaxel in older adults with ovarian cancer: a retrospective study. (5 déc. 2025)
- Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 Study. (11 nov. 2025)
- PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: Rationale, Mechanisms, and Clinical Applications. (10 nov. 2025)
- The CD70-CD27 Axis in Cancer Immunotherapy: Predictive Biomarker and Therapeutic Target. (15 juil. 2025)
- Cabozantinib plus atezolizumab in metastatic prostate cancer (CONTACT-02): final analyses from a phase 3, open-label, randomised trial. (1 juil. 2025)